INVISIO: Invitation to Q1 2017 conference call on April 27 at 10.00 CET

Stockholm, April 20, 2017
 

INVISIO is pleased to invite press, investors and analysts to a conference call on April 27, 2017 at 10.00 CET where CEO Lars Højgård Hansen and CFO Thomas Larsson present the INVISIO 2017 first quarter results.

The conference call, which will be held in English, will begin with a presentation of the interim results followed by a Q&A session.

The interim report for January-March 2017 will be announced on April 26.

Phone number for the conference:
To participate in the conference call, use the dial-in numbers below. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.

Sweden: +46(0)8 5033 6539
Denmark: +4532 71 16 58
UK: +44(0)20 3427 1919
Germany: +49(0)69 2222 10628
France: +33(0)1 76 77 22 25

Confirmation code: 6809580

Webcast
To follow the presentation via the web, please use this link:
http://edge.media-server.com/m/p/rkr8ha3y  


For additional information, please contact:
Lars Højgård Hansen, CEO, INVISIO Communications
Mobile: + 45 53 72 77 22 | E-mail: lhh@invisio.com

Tina Dackemark Lawesson, Director Investor Relations & Corporate Communications
Mobile: + 45 53 72 7733 | E-mail: tdl@invisio.com


About INVISIO Communications AB (publ)
INVISIO offers cutting-edge personal communication and hearing protection systems. The systems enable users to operate and communicate safely and clearly in all environments, even under extreme conditions, such as loud noise, heat, and underwater. INVISIO systems consist of headsets and advanced control units that interface to a wide range of communication devices. The systems provide hearing protection while maintaining the natural level of situational awareness. Customers are mainly from the public sector. Sales are made via a global network of partners and to some extent directly to end customers. INVISIO is listed on Nasdaq Stockholm (IVSO). Additional information is available on the company's website, www.invisio.com.